| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18476f8794a7dd2d74327e1256e829e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf37fb6e2259792455c1718fec3da0e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e952589877df0a79d5ac37d23f29b45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931cf937486ea0d91f896e27e6f43069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_536f001e42b4421737473b6644539991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1f027c0e8d68c43a255a21c5396edff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16023 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-125 |
| filingDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de526220069eec15487e032b8395dfb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c8d59c96972c52857f21e47f19da3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec49c645da90ee8a3f39783ac8946955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0bf8a42b9ada9d64da607053fa776fa |
| publicationDate |
2007-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007008093-A2 |
| titleOfInvention |
A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine |
| abstract |
The subject of the present invention is a method of manufacturing a recombinant vaccine against rabbit viral haemorrhagic disease, the vaccine and the application of a recombinant protein antigen in the manufacture of the vaccine. The subjects of the present invention facilitate the production of a recombinant capsid protein exhibiting hemagglutinin and antigenic properties, which is able to form virus-like particles (VLP) and to stimulate the production of specific antibodies in inoculated animals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112480269-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023014983-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115444933-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115444933-A |
| priorityDate |
2005-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |